| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 0.00 | AU$ 23.49M | AU$ 22.06M | AU$ 15.81M | AU$ 16.04M |
| Gross Profit | AU$ -1.20M | AU$ 23.49M | AU$ 22.06M | AU$ 14.92M | AU$ 15.20M |
| Operating Income | AU$ -82.67M | AU$ -53.63M | AU$ -38.86M | AU$ -39.16M | AU$ -30.21M |
| EBITDA | AU$ -81.47M | AU$ -52.88M | AU$ -54.55M | AU$ -38.25M | AU$ -29.39M |
| Net Income | AU$ -43.34M | AU$ -50.30M | AU$ -37.73M | AU$ -22.79M | AU$ -13.86M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 447.56M | AU$ 153.05M | AU$ 66.87M | AU$ 15.57M | AU$ 29.11M |
| Total Assets | AU$ 708.52M | AU$ 183.28M | AU$ 91.24M | AU$ 37.17M | AU$ 45.35M |
| Total Debt | AU$ 624.99K | AU$ 1.02M | AU$ 1.11M | AU$ 315.49K | AU$ 943.77K |
| Net Debt | AU$ -52.94M | AU$ -152.03M | AU$ -65.76M | AU$ -15.26M | AU$ -28.17M |
| Total Liabilities | AU$ 15.18M | AU$ 13.27M | AU$ 10.18M | AU$ 8.72M | AU$ 5.15M |
| Stockholders' Equity | AU$ 693.33M | AU$ 169.57M | AU$ 80.50M | AU$ 27.75M | AU$ 39.35M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -45.05M | AU$ -52.54M | AU$ -38.90M | AU$ -24.91M | AU$ -22.17M |
| Operating Cash Flow | AU$ -44.52M | AU$ -51.56M | AU$ -38.59M | AU$ -24.42M | AU$ -21.78M |
| Investing Cash Flow | AU$ -616.16M | AU$ -975.40K | AU$ -307.04K | AU$ -477.12K | AU$ 32.68M |
| Financing Cash Flow | AU$ 563.22M | AU$ 138.66M | AU$ 90.19M | AU$ 11.44M | AU$ -182.36K |
PYC Therapeutics Limited (PYCXF)
OTHER OTC:PYCXF
